EMERSONS PLANTWEB ARCHITECTURE TO DIGITALLY AUTOMATE NEW PLANT FOR FIRST MONOCLONAL ANTIBODY DRUGS IN CHINA

Emerson Automation Solutions 07/04/2008

89 2 minutes read

Listen to this article

Emerson Process Management has been chosen to design and install its advanced PlantWeb digital plant architecture to digitally automate Shanghai CP Guojian Pharmaceutical Companys new API production suite, which will have the largest mammalian cell-culture system in Asia. Located in the Zhangjiang Hi-Tech Park in Shanghai, the new plant is expected to begin producing the first monoclonal antibody drugs in China by August, 2008.

Emerson was selected by M+W Zander of Shanghai, the engineering procurement contractor, to design the plants automation approach to take advantage of PlantWeb architecture with FOUNDATION fieldbus instrumentation for networking intelligent process instrumentation. The PlantWeb approach will use its DeltaV digital automation system to also integrate variable frequency drives using DeviceNet, and all On/Off valves using AS-i bus. Integration with the DeltaV systems speeds installation and commissioning for fast start-up which is key for biopharmaceutical plants, and also includes DeltaV Batch software for process optimisation and streamlined compliance.

To further speed start-up, Emerson is supplying its AMS Suite software that communicates with smart field devices for efficient commissioning. Later, AMS Suite will enable predictive maintenance by monitoring diagnostics running in field instrumentation and alerting plant personnel to issues that need maintenance attention before they affect or shut down operations. The instrumentation includes Emersons Rosemount temperature transmitters, pressure transmitters, and flow meters as well as Fisher control valves with FIELDVUE digital valve controllers that are also being deployed in key locations throughout the process.

Emersons solution will reduce the complexity of field wiring and support asset management of the smart field devices. The fieldbus technology will be applied to all process control valves and many of the plants 2000 analogue input/output control signals. Emerson engineers will also configure and integrate all field devices with the control system and provide necessary on-site services to validate the system before start-up.

“Emerson has demonstrated high capability in pharmaceutical applications, and their engineers are very experienced in adapting the fieldbus technology to batch production systems,” said Mr. David Liu, project manager for M+W Zander. “Our customer has great confidence in their ability to deliver an advanced solution for this unique process.”

The Emerson solution is intended to meet the end-users goal of applying the most advanced technology to all phases of pharmaceutical production while keeping costs low, meeting the construction schedule, and achieving a smooth start-up. Company officials expect to meet international standards with the products of this facility.

For more information contact Emerson Process Management, Stockport, Cheshire

Tel: 0870 240 1978 (UK) +44 870 240 1978 (Int)

Fax: 0870 240 4389 (UK) +44 870 240 4389 (Int)

Email: uk-irelandsales@EmersonProcess.com Web: www.EmersonProcess.eu

Contact Details

Emerson Automation Solutions

0870 240 1978
uksales@emerson.com
Meridian East, Meridian Business Park, Leicester, Leicestershire LE19 1UX GB

About us

Leader in helping businesses automate their production, processing and distribution in the chemical, oil and gas, refining, pulp and paper, power, water and wastewater treatment, mining and metals, food and beverage, life sciences and other industries.

Where we supply to

Europe, Africa, Asia, Australia, South America, North America

Industries we supply to

Automation, Chemicals, Consultants, Components Electronics, Energy and Power, Food and Beverage, Glass Ceramics Cement, Metals and Minerals, OEM, Paper and Pulp, Pharmaceutical Cosmetics Toiletries, Plastics and Rubber, Recycling, Textiles, Tobacco, Water and Wastewater